Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.15 – $13.93
82% from low
No one on the platform currently holds GLASF.
No tracked institution reports a position in GLASF as of their last filing.
No one on the platform has traded GLASF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $213M | +16.9% | $-0.10 | $-0.10–$-0.09 | — | 1 |
| 2027 | $260M | +22.0% | $0.24 | $0.23–$0.26 | 50.4× | 1 |
| 2028 | $272M | +4.4% | $0.43 | $0.40–$0.46 | 28.7× | 1 |
| 2029 | $344M | +26.7% | $0.81 | $0.76–$0.86 | 15.2× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-13 | $-0.17 | $-0.21 | -22.9% |
| 2026-03-24 | $-0.19 | $-0.20 | -6.7% |
| 2025-11-12 | $-0.20 | $-0.15 | +25.6% |
| 2025-08-13 | $-0.01 | $0.10 | +798.0% |
| 2025-05-12 | $-0.14 | $-0.18 | -28.6% |
| 2025-03-26 | $-0.10 | $-0.05 | +50.0% |
| 2024-11-13 | $0.01 | $-0.09 | -1900.0% |
| 2024-08-13 | $-0.39 |
| $0.08 |
| +120.5% |
| $338M |
| — |
| HUMDFHua Medicine (Shanghai) Ltd. | $0.31 | +0.00% | $313M | — |
| JCRRFJCR Pharmaceuticals Co., Ltd. | $3.32 | +0.00% | $405M | — |
Source: Financial Modeling Prep · peers by sector/industry